The effect of zanamivir treatment on the early immune response to influenza vaccination (Q43727744)

26 November 2017

The effect of zanamivir treatment on the early immune response to influenza vaccination (English)

1 reference

26 November 2017

1 reference

Cox RJ

1

1 reference

26 November 2017

Mykkeltvedt E

series ordinal

2

1 reference

26 November 2017

Sjursen H

series ordinal

3

1 reference

26 November 2017

Haaheim LR

series ordinal

4

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

26 November 2017

7

1 reference

inferred from page(s)

published in

Vaccine

1 reference

26 November 2017

19

1 reference

26 November 2017

32

1 reference

26 November 2017

4743-4749

1 reference

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900219-5

7 January 2021

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900219-5

7 January 2021

Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900219-5

7 January 2021

Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900219-5

7 January 2021

Rapid immune response to influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900219-5

7 January 2021

An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900219-5

7 January 2021

Parenteral influenza vaccination induces a rapid systemic and local immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900219-5

7 January 2021

Coadministration of orally inhaled zanamivir with inactivated trivalent influenza vaccine does not adversely affect the production of antihaemagglutinin antibodies in the serum of healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900219-5

7 January 2021

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900219-5

7 January 2021

Systemic and local immune responses after parenteral influenza vaccination in juvenile diabetic patients and healthy controls: results from a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900219-5

7 January 2021

Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900219-5

7 January 2021

Immunoglobulin G, A and M response to influenza vaccination in different age groups: effects of priming and boosting

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900219-5

7 January 2021

IgA, IgA subclasses, and secretory component levels in oral fluid collected from subjects after parental influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900219-5

7 January 2021

Possible correlation between low antigenic drift of A(H1N1) influenza viruses and induction of HI antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900219-5

7 January 2021

Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900219-5

7 January 2021

10.1016/S0264-410X(01)00219-5

Identifiers

DOI

1 reference

26 November 2017

1 reference